Value of surfactant replacement therapy in the treatment of acute respiratory distress syndrome;(K)eine surfactant-therapie bei patienten mit "acute respiratory distress syndrome"? Bedeutung einer surfactant-substitutionstherapie in der behandlung des akuten lungenversagens

Anaesthesist

Volumn 55, Issue 4, 2006, Pages 433-442

  Lauer, S ^a   Fischer, L ^a   Stubbe, H ^a   Van Aken, H ^a   Westphal, M ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Adult patients; Surfactant replacement therapy; Surfactant system dysfunction

Indexed keywords

BERACTANT; CALFACTANT; DIPALMITOYLPHOSPHATIDYLCHOLINE; HL 10; LUCINACTANT; LUSUPULTIDE; PORACTANT; PUMACTANT; SURFACTANT; UNCLASSIFIED DRUG;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CLINICAL PROTOCOL; CLINICAL RESEARCH; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; HUMAN; LUNG INJURY; RESPIRATORY FAILURE; SEPSIS;

HUMANS; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY FUNCTION TESTS;

EID: 33646250421     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-006-0978-7     Document Type: Article

References (68)

1. Abel SJ, Finney SJ, Brett SJ, Keogh BF, Morgan CJ, Evans TW (1998) Reduced mortality in association with the acute respiratory distress syndrome (ARDS). Thorax 53:292-294
2. Anzueto A (2002) Exogenous surfactant in acute respiratory distress syndrome: more is better. Eur Respir J 19:787-789
3. Anzueto A, Baughman RP, Guntupalli KK et al. (1996) Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med 334:1417-1421
4. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE (1967) Acute respiratory distress in adults. Lancet 2:319-323
5. Balaraman V, Sood SL, Finn KC, Hashiro G, Uyehara CF, Easa D (1996) Physiologic response and lung distribution of lavage versus bolus Exosurf in piglets with acute lung injury. Am J Respir Crit Care Med 153:1838-1843
6. Balaraman V, Meister J, Ku TL et al. (1998) Lavage administration of dilute surfactants after acute lung injury in neonatal piglets. Am J Respir Crit Care Med 158:12-17
7. Bernard GR, Artigas A, Brigham KL et al. (1994) The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149:818-824
8. Cheng IW, Ware LB, Greene KE, Nuckton TJ, Eisner MD, Matthay MA (2003) Prognostic value of surfactant proteins A and D in patients with acute lung injury. Crit Care Med 31:20-27
9. Cochrane CG, Revak SD, Merritt TA et al. (1998) Bronchoalveolar lavage with KL4-surfactant in models of meconium aspiration syndrome. Pediatr Res 44:705-715
10. Crouch E, Wright JR (2001) Surfactant proteins a and d and pulmonary host defense. Annu Rev Physiol 63:521-554
11. Fujiwara T, Maeta H, Chida S, Morita T, Watabe Y, Abe T (1980) Artificial surfactant therapy in hyaline-membrane disease. Lancet 1:55-59
12. Gilliard N, Richman PM, Merritt TA, Spragg RG (1990) Effect of volume and dose on the pulmonary distribution of exogenous surfactant administered to normal rabbits or to rabbits with oleic acid lung injury. Am Rev Respir Dis 141:743-747
13. Goerke J (1998) Pulmonary surfactant: functions and molecular composition. Biochim Biophys Acta 1408:79-89
14. Gregory TJ, Longmore WJ, Moxley MA et al. (1991) Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 88:1976-1981
15. Gregory TJ, Steinberg KP, Spragg R et al. (1997) Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 155:1309-1315
16. Gregory TJ, Hite RD, Hicklin G (2003) Dose escalation study of surfaxin delivered via bronchopulmonary segmental lavage (BPSL) in patients with ARDS. Am J Respir Crit Care Med 167:A178
17. Gunther A, Siebert C, Schmidt R et al. (1996) Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 153:176-184
18. Hafner D, Germann PG, Hauschke D (1998) Effects of rSP-C surfactant on oxygenation and histology in a rat-lung-lavage model of acute lung injury. Am J Respir Crit Care Med 158:270-278
19. Hafner D, Germann PG, Hauschke D (1998) Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndrome. Br J Pharmacol 124:1083-1090
20. Haitsma JJ, Papadakos PJ, Lachmann B (2004) Surfactant therapy for acute lung injury/acute respiratory distress syndrome. Curr Opin Crit Care 10:18-22
21. Hite RD, Seeds MC, Jacinto RB, Balasubramanian R, Waite M, Bass D (1998) Hydrolysis of surfactant-associated phosphatidylcholine by mammalian secretory phospholipases A2. Am J Physiol 275:L740-747
22. Hite RD, Seeds MC, Safta AM, Jacinto RB, Gyves JI, Bass DA, Waite BM (2005) Lysophospholipid generation and phosphatidylglycerol depletion in phospholipase A(2)-mediated surfactant dysfunction. Am J Physiol Lung Cell Mol Physiol 288:L618-624
23. Holm BA, Matalon S (1989) Role of pulmonary surfactant in the development and treatment of adult respiratory distress syndrome. Anesth Analg 69:805-818
24. Ito Y, Goffin J, Veldhuizen R et al. (1996) Timing of exogenous surfactant administration in a rabbit model of acute lung injury. J Appl Physiol 80:1357-1364
25. Kerr CL, Ito Y, Manwell SE, Veldhuizen RA, Yao LJ, McCaig LA, Lewis JF (1998) Effects of surfactant distribution and ventilation strategies on efficacy of exogenous surfactant. J Appl Physiol 85:676-684
26. Kesecioglu JSM, Lundberg D, Lauven PM, Lachmann B (2001) Treatment of acute lung injury (ALI/ARDS) with surfactant. Am J Respir Crit Care Med 163:A819
27. King R (1984) Isolation and chemical composition of pulmonary surfactant. In: Robertson B, Golde LMG van, Batenburg JJ (eds) Pulmonary surfactant. Elsevier, Amsterdam, pp 1-15
28. Lee CT, Fein AM, Lippmann M, Holtzman H, Kimbel P, Weinbaum G (1981) Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory-distress syndrome. N Engl J Med 304:192-196
29. Lewis JF, Brackenbury A (2003) Role of exogenous surfactant in acute lung injury. Crit Care Med 31:S324-328
30. Lewis JF, Jobe AH (1993) Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis 147:218-233
31. Lewis JF, McCaig L (1993) Aerosolized versus instilled exogenous surfactant in a nonuniform pattern of lung injury. Am Rev Respir Dis 148:1187-1193
32. Lewis JF, Veldhuizen R (2003) The role of exogenous surfactant in the treatment of acute lung injury. Annu Rev Physiol 65:613-642
33. Lewis JF, Tabor B, Ikegami M, Jobe AH, Joseph M, Absolom D (1993) Lung function and surfactant distribution in saline-lavaged sheep given instilled vs. nebulized surfactant. J Appl Physiol 74:1256-1264
34. Lewis JF, Ikegami M, Jobe AH, Absolom D (1993) Physiologic responses and distribution of aerosolized surfactant (Survanta) in a nonuniform pattern of lung injury. Am Rev Respir Dis 147:1364-1370
35. Lewis JF, Goffin J, Yue P, McCaig LA, Bjarneson D, Veldhuizen RA (1996) Evaluation of exogenous surfactant treatment strategies in an adult model of acute lung injury. J Appl Physiol 80:1156-1164
36. Malherbe DC, Erpenbeck VJ, Abraham SN, Crouch EC, Hohlfeld JM, Wright JR (2005) Surfactant protein D decreases pollen-induced IgE-dependent mast cell degranulation. Am J Physiol Lung Cell Mol Physiol 289(5):L856-866
37. Malloy JL, Veldhuizen RA, Lewis JF (2000) Effects of ventilation on the surfactant system in sepsis-induced lung injury. J Appl Physiol 88:401-408
38. McCormack FX, Whitsett JA (2002) The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J Clin Invest 109:707-712
39. Meister J, Balaraman V, Ramirez M et al. (2004) Lavage administration of dilute surfactant in a piglet model of meconium aspiration. Lung 182:227-240
40. Meister JC, Balaraman V, Ku T et al. (2000) Lavage administration of dilute recombinant surfactant in acute lung injury in piglets. Pediatr Res 47:240-245
41. Moya FR, Gadzinowski J, Bancalari E et al. (2005) A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants. Pediatrics 115:1018-1029
42. Nogee LM, Garnier G, Dietz HC, Singer L, Murphy AM, Mello DE de, Colten HR (1994) A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 93:1860-1863
43. Ohama Y, Ogawa Y (1999) Treatment of meconium aspiration syndrome with surfactant lavage in an experimental rabbit model. Pediatr Pulmonol 28:18-23
44. Paranka MS, Walsh WF, Stancombe BB (1992) Surfactant lavage in a piglet model of meconium aspiration syndrome. Pediatr Res 31:625-628
45. Petty TL, Reiss OK, Paul GW, Silvers GW, Elkins ND (1977) Characteristics of pulmonary surfactant in adult respiratory distress syndrome associated with trauma and shock. Am Rev Respir Dis 115:531-536
46. Petty TL, Silvers GW, Paul GW, Stanford RE (1979) Abnormalities in lung elastic properties and surfactant function in adult respiratory distress syndrome. Chest 75:571-574
47. Pison U, Gono E, Joka T, Obertacke U (1987) Phospholipid lung profile in adult respiratory distress syndrome - Evidence for surfactant abnormality. Prog Clin Biol Res 236:A517-523
48. Pison U, Max M, Neuendank A, Weissbach S, Pietschmann S (1994) Host defence capacities of pulmonary surfactant: evidence for "non-surfactant" functions of the surfactant system. Eur J Clin Invest 24:586-599
49. Possmayer F, Yu SH, Weber JM, Harding PG (1984) Pulmonary surfactant. Can J Biochem Cell Biol 62:1121-1133
50. Postle AD, Heeley EL, Wilton DC (2001) A comparison of the molecular species compositions of mammalian lung surfactant phospholipids. Comp Biochem Physiol A Mol Integr Physiol 129:65-73
51. Robertson B (1989) Background to neonatal respiratory distress syndrome and treatment with exogenous surfactant. Dev Pharmacol Ther 13:159-163
52. Rocco PR, Zin WA (2005) Pulmonary and extrapulmonary acute respiratory distress syndrome: are they different? Curr Opin Crit Care 11:10-17
53. Rooney SA (2001) Regulation of surfactant secretion. Comp Biochem Physiol A Mol Integr Physiol 129:233-243
54. Schmidt R, Meier U, Yabut-Perez M, Walmrath D, Grimminger F, Seeger W, Gunther A (2001) Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia. Am J Respir Crit Care Med 163:95-100
55. Schultz MJ, Kesecioglu J (2004) Is surfactant a promising additive drug in ALI/ARDS-patients? Curr Drug Targets 5:445-448
56. Seeger W, Elssner A, Gunther A, Kramer HJ, Kalinowski HO (1993) Lung surfactant phospholipids associate with polymerizing fibrin: loss of surface activity. Am J Respir Cell Mol Biol 9:213-220
57. Segerer H, Gelder W van, Angenent FW, Woerkens LJ van, Curstedt T, Obladen M, Lachmann B (1993) Pulmonary distribution and efficacy of exogenous surfactant in lung-lavaged rabbits are influenced by the instillation technique. Pediatr Res 34:490-494
58. Spragg RG, Lewis JF, Walmrath HD et al. (2004) Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med 351:884-892
59. Strohmaier W, Trupka A, Pfeiler C et al. (2005) Bilateral lavage with diluted surfactant improves lung function after unilateral lung contusion in pigs. Crit Care Med 33:2286-2293
60. Tokieda K, Whitsett JA, Clark JC et al. (1997) Pulmonary dysfunction in neonatal SP-B-deficient mice. Am J Physiol 273:L875-882
61. Uhlig S, Brasch F, Wollin L, Fehrenbach H, Richter J, Wendel A (1995) Functional and fine structural changes in isolated rat lungs challenged with endotoxin ex vivo and in vitro. Am J Pathol 146:1235-1247
62. Veldhuizen RA, Tremblay LN, Govindarajan A, Rozendaal BA van, Haagsman HP, Slutsky AS (2000) Pulmonary surfactant is altered during mechanical ventilation of isolated rat lung. Crit Care Med 28:2545-2551
63. Ware LB, Matthay MA (2000) The acute respiratory distress syndrome. N Engl J Med 342:1334-1349
64. Weaver TE, Conkright JJ (2001) Function of surfactant proteins B and C. Annu Rev Physiol 63:555-578
65. Weg JG, Balk RA, Tharratt RS et al. (1994) Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome. JAMA 272:1433-1438
66. Westphal M, Traber DL (2005) Exogenous surfactant in acute lung injury: no longer a question? Crit Care Med 33:2431-2433
67. Wiswell TE, Smith RM, Katz LB et al. (1999) Bronchopulmonary segmental lavage with Surfaxin (KL(4)-surfactant) for acute respiratory distress syndrome. Am J Respir Crit Care Med 160:1188-1195
68. Wright JR, Hawgood S (1989) Pulmonary surfactant metabolism. Clin Chest Med 10:83-93